Calcium and neurogenesis in Alzheimer's disease

Frontiers in Neuroscience

Volumn 4, Issue DEC, 2010, Pages

  Wang, Jun Ming ^a   Sun, Chenyou ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Allopregnanolone; Alzheimer's disease; Calcium homeostasis; Neurogenesis

Indexed keywords

EID: 84858291182     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2010.00194     Document Type: Article

References (69)

1. Aguzzi, A., and Rajendran, L. (2009). The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 64, 783-790.
2. Aizawa, K., Ageyama, N., Yokoyama, C., and Hisatsune, T. (2009). Age-dependent alteration in hippocampal neurogenesis correlates with learning performance of macaque monkeys. Exp. Anim. 58, 403-407.
3. Aizawa, K., Ageyama, N., Terao, K., and Hisatsune, T. (2011). Primate-specific alterations in neural stem/progenitor cells in the aged hippocampus. Neurobiol. Aging. 32, 140-150.
4. Belelli, D., Herd, M. B., Mitchell, E. A., Peden, D. R., Vardy, A. W., Gentet, L., and Lambert, J. J. (2006). Neuroactive steroids and inhibitory neurotransmission: mechanisms of action and physiological relevance. Neuroscience 138, 821-829.
5. Belelli, D., and Lambert, J. J. (2005). Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat. Rev. Neurosci. 6, 565-575.
6. Ben-Ari, Y. (2002). Excitatory actions of gaba during development: the nature of the nurture. Nat. Rev. Neurosci. 3, 728-739.
7. Ben-Ari, Y., Gaiarsa, J. L., Tyzio, R., and Khazipov, R. (2007). GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol. Rev. 87, 1215-1284.
8. Berridge, M. J. (1995). Calcium signalling and cell proliferation. Bioessays 17, 491-500.
9. Bickeboller, H., Campion, D., Brice, A., Amouyel, P., Hannequin, D., Didierjean, O., Penet, C., Martin, C., Perez-Tur, J., Michon, A., Dubois, B., Ledoze, F., Thomas-Anterion, C., Pasquier, F., Puel, M., Demonet, J.F., Moreaud, O., Babron, M.C., Meulien, D., Guez, D., Chartier-Harlin, M.C., Frebourg, T., Agid, Y., Martinez, M., and Clerget-Darpoux, F. (1997). Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am. J. Hum. Genet. 60, 439-446.
10. Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., and LaFerla, F. M. (2005). Intraneuronal Abeta causes the onset of early Alzheimers disease-related cognitive deficits in transgenic mice. Neuron 45, 675-688.
11. Brinton, R. D. (1994). The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one induces cytoarchitectural regression in cultured fetal hippocampal neurons. J. Neurosci. 14.
12. Brinton, R. D., and Wang, J. M. (2006). Preclinical analyses of the therapeutic potential of allopregnanolone to promote neurogenesis in vitro and in vivo in transgenic mouse model of Alzheimer's disease. Curr. Alzheimer Res. 3, 11-17.
13. Chao, T. S., Byron, K. L., Lee, K. M., Villereal, M., and Rosner, M. R. (1992). Activation of MAP kinases by calcium-dependent and calcium-independent pathways. Stimulation by thapsigargin and epidermal growth factor. J. Biol. Chem. 267, 19876-19883.
14. Chen, S., Wang, J., Irwin, R. W., Yao, J., Liu, L., Hamilton, R. T., Lemus, J., and Brinton, R. D. (2009). Allopregnanolone Promotes Myelin Formation Associated with Decreased Accumulation of Amyloid b in the Triple Transgenic Mouse Model of Alzheimer's Disease. Program No. 543.2. Neuroscience Meeting Planner. Chicago, IL: Society for Neuroscience [online].
15. Colombo, P. J., and Gallagher, M. (2002). Individual differences in spatial memory among aged rats are related to hippocampal PKCgamma immunoreactivity. Hippocampus 12, 285-289.
16. Colombo, P. J., Wetsel, W. C., and Gallagher, M. (1997). Spatial memory is related to hippocampal subcellular concentrations of calcium-dependent protein kinase C isoforms in young and aged rats. Proc. Natl. Acad. Sci. U.S.A. 94, 14195-14199.
17. Dayanithi, G., and Tapia-Arancibia, L. (1996). Rise in intracellular calcium via a nongenomic effect of allopregnanolone in fetal rat hypothalamic neurons. J. Neurosci. 16, 130-136
18. Demars, M., Hu, Y. S., Gadadhar, A., and Lazarov, O. (2010). Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice. J. Neurosci. Res. 88, 2103-2117.
19. Dickson, D. W. (2004). Building a more perfect beast: APP transgenic mice with neuronal loss. Am. J. Pathol. 164, 1143-1146.
20. Dong, H., Goico, B., Martin, M., Csernansky, C. A., Bertchume, A., and Csernansky, J. G. (2004). Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience 127, 601-609.
21. Donovan, M. H., Yazdani, U., Norris, R. D., Games, D., German, D. C., and Eisch, A. J. (2006). Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease. J. Comp. Neurol. 495, 70-83.
22. Dreses-Werringloer, U., Lambert, J. C., Vingtdeux, V., Zhao, H., Vais, H., Siebert, A., Jain, A., Koppel, J., Rovelet-Lecrux, A., Hannequin, D., Pasquier, F., Galimberti, D., Scarpini, E., Mann, D., Lendon, C. Campion, D., Amouyel, P., Davies, P., Foskett, J. K., Campagne, F., and Marambaud, P. (2008). A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk. Cell 133, 1149-1161.
23. Gage, F. H., Kempermann, G., Palmer, T. D., Peterson, D. A., and Ray, J. (1998). Multipotent progenitor cells in the adult dentate gyrus. J. Neurobiol. 36, 249-266.
24. Gago, N., El-Etr, M., Sananes, N., Cadepond, F., Samuel, D., Avellana-Adalid, V., Baron-Van Evercooren, A., and Schumacher, M. (2004). 3alpha,5alpha-Tetrahydroprogesterone (allopregnanolone) and gamma-aminobutyric acid: autocrine/paracrine interactions in the control of neonatal PSA-NCAM+ proliferation. J. Neurosci. Res. 78, 770-783.
25. Gandy, S., Doeven, M. K., and Poolman, B. (2006). Alzheimer disease: presenilin springs a leak. Nat. Med. 12, 1121-1123.
26. Gomez-Lechon, M. J., Guillen, I., Ponsoda, X., Fabra, R., Trullenque, R., Nakamura, T., and Castell, J. V. (1996). Cell cycle progression proteins (cyclins), oncogene expression, and signal transduction during the proliferative response of human hepatocytes to hepatocyte growth factor. Hepatology 23, 1012-1019.
27. Gomez, T. M., and Spitzer, N. C. (2000). Regulation of growth cone behavior by calcium: new dynamics to earlier perspectives. J. Neurobiol. 44, 174-183.
28. Green, K. N., and LaFerla, F. M. (2008). Linking calcium to Abeta and Alzheimer's disease. Neuron 59, 190-194.
29. Haass, C., and Selkoe, D. J. (2007). Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8, 101-112.
30. Hardy, J. (2006). A hundred years of Alzheimer's disease research. Neuron 52, 3-13.
31. Haughey, N. J., Nath, A., Chan, S. L., Borchard, A. C., Rao, M. S., and Mattson, M. P. (2002). Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J. Neurochem. 83, 1509-1524.
32. Hosie, A. M., Wilkins, M. E., da Silva, H. M., and Smart, T. G. (2006). Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature 444, 486-489.
33. Komuro, H., and Rakic, P. (1996). Intracellular Ca2+ fluctuations modulate the rate of neuronal migration. Neuron 17, 275-285.
34. Kruman, I., Guo, Q., and Mattson, M. P. (1998). Calcium and reactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells. J. Neurosci. Res. 51, 293-308
35. LaFerla, F. M., Troncoso, J. C., Strickland, D. K., Kawas, C. H., and Jay, G. (1997). Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization. J. Clin. Invest. 100, 310-320.
36. Marambaud, P., Dreses-Werringloer, U., and Vingtdeux, V. (2009). Calcium signaling in neurodegeneration. Mol. Neurodegener. 4, 20.
37. Mattson, M. P. (2004). Pathways towards and away from Alzheimer's disease. Nature 430, 631-639.
38. McDonald, R. J., Craig, L. A., and Hong, N. S. (2010). The etiology of age-related dementia is more complicated than we think. Behav. Brain Res. 214, 3-11.
39. McKee, A. C., Carreras, I., Hossain, L., Ryu, H., Klein, W. L., Oddo, S., LaFerla, F. M., Jenkins, B. G., Kowall, N. W., and Dedeoglu, A. (2008). Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice. Brain Res. 1207, 225-236.
40. Murray, F. E., Landsberg, J. P., Williams, R. J., Esiri, M. M., and Watt, F. (1992). Elemental analysis of neurofibrillary tangles in Alzheimer's disease using proton-induced X-ray analysis. Ciba Found. Symp. 169, 201-210; discussion 210-206.
41. Nimmrich, V., Grimm, C., Draguhn, A., Barghorn, S., Lehmann, A., Schoemaker, H., Hillen, H., Gross, G., Ebert, U., and Bruehl, C. (2008). Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. J. Neurosci. 28, 788-797.
42. Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., Berry, R., and Vassar, R. (2006). Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129-10140.
43. Obrietan, K., and van den Pol, A. N. (1996). Growth cone calcium elevation by GABA. J. Comp. Neurol. 372, 167-175.
44. Perisse, E., Raymond-Delpech, V., Neant, I., Matsumoto, Y., Leclerc, C., Moreau, M., and Sandoz, J. C. (2009). Early calcium increase triggers the formation of olfactory long-term memory in honeybees. BMC Biol. 7, 30. doi: 10.1186/1741-7007-7-30.
45. Rajendran, L., Knolker, H. J., and Simons, K. (2010). Subcellular targeting strategies for drug design and delivery. Nat. Rev. Drug Discov. 9, 29-42.
46. Rao, M. S., Hattiangady, B., Abdel-Rahman, A., Stanley, D. P., and Shetty, A. K. (2005). Newly born cells in the ageing dentate gyrus display normal migration, survival and neuronal fate choice but endure retarded early maturation. Eur. J. Neurosci. 21, 464-476.
47. Ratan, R. R., Maxfield, F. R., and Shelanski, M. L. (1988). Long-lasting and rapid calcium changes during mitosis. J. Cell Biol. 107, 993-999.
48. Reddy, G. P. (1994). Cell cycle: regulatory events in G1→S transition of mammalian cells. J. Cell. Biochem. 54, 379-386.
49. Rockenstein, E., Crews, L., and Masliah, E. (2007). Transgenic animal models of neurodegenerative diseases and their application to treatment development. Adv. Drug Deliv. Rev. 59, 1093-1102.
50. Rodriguez, J. J., Jones, V. C., Tabuchi, M., Allan, S. M., Knight, E. M., LaFerla, F. M., Oddo, S., and Verkhratsky, A. (2008). Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease. PLoS ONE 3, e2935. doi: 10.1371/journal.pone.0002935.
51. Scheff, S. W., and Price, D. A. (2003). Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol. Aging 24, 1029-1046.
52. Scheff, S. W., Price, D. A., Schmitt, F. A., and Mufson, E. J. (2006). Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging 27, 1372-1384.
53. Seo, S. R., and Seo, J. T. (2009). Calcium overload is essential for the acceleration of staurosporine-induced cell death following neuronal differentiation in PC12 cells. Exp. Mol. Med. 41, 269-276.
54. Shetty, A. K., Hattiangady, B., and Shetty, G. A. (2005). Stem/progenitor cell proliferation factors FGF-2, IGF-1, and VEGF exhibit early decline during the course of aging in the hippocampus: role of astrocytes. Glia. 51, 173-186.
55. Smith, I. F., Green, K. N., and LaFerla, F. M. (2005). Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals. Cell Calcium 38, 427-437.
56. Spitzer, N. C. (2008). Calcium: first messenger. Nat. Neurosci. 11, 243-244.
57. Spitzer, N. C., Olson, E., and Gu, X. (1995). Spontaneous calcium transients regulate neuronal plasticity in developing neurons. J. Neurobiol. 26, 316-324.
58. Tu, H., Nelson, O., Bezprozvanny, A., Wang, Z., Lee, S. F., Hao, Y. H., Serneels, L., De Strooper, B., Yu, G., and Bezprozvanny, I. (2006). Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 126, 981-993.
59. Viero, C., Mechaly, I., Aptel, H., Puech, S., Valmier, J., Bancel, F., and Dayanithi, G. (2006). Rapid inhibition of Ca2+ influx by neurosteroids in murine embryonic sensory neurones. Cell Calcium 40, 383-391.
60. Wang, J. M., and Brinton, R. D. (2008). Allopregnanolone-induced rise in intracellular calcium in embryonic hippocampal neurons parallels their proliferative potential. BMC Neurosci. 9(Suppl. 2), S11. doi: 10.1186/1471-2202-9-S2-S11.
61. Wang, J. M., Irwin, R. W., Liu, L., Chen, S., and Brinton, R. D. (2007). Regeneration in a degenerating brain: potential of allopregnanolone as a neuroregenerative agent. Curr. Alzheimer Res. 4, 510-517.
62. Wang, J. M., Johnston, P. B., Ball, B. G., and Brinton, R. D. (2005). The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression. J. Neurosci. 25, 4706-4718.
63. Wang, D. D., Kriegstein, A. R., and Ben-Ari, Y. (2008a). GABA regulates stem cell proliferation before nervous system formation. Epilepsy Curr. 8, 137-139.
64. Wang, J. M., Liu, L., Irwin, R. W., Chen, S., and Brinton, R. D. (2008b). Regenerative potential of allopregnanolone. Brain Res. Rev. 57, 398-409.
65. Wang, L., Chopp, M., Gregg, S. R., Zhang, R. L., Teng, H., Jiang, A., Feng, Y., and Zhang, Z. G. (2008c). Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF. J. Cereb. Blood Flow Metab. 28, 1361-1368.
66. Wang, J. M., Singh, C., Liu, L., Irwin, R. W., Chen, S., Chung, E. J., Thompson, R. F., and Brinton, R. D. (2010). Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 107, 6498-6503.
67. Wen, P. H., Hof, P. R., Chen, X., Gluck, K., Austin, G., Younkin, S. G., Younkin, L. H., DeGasperi, R., Gama Sosa, M. A., Robakis, N. K., Haroutunian, V., and Elder, G. A. (2004). The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice. Exp. Neurol. 188, 224-237.
68. Zhang, C., McNeil, E., Dressler, L., and Siman, R. (2007). Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease. Exp. Neurol. 204, 77-87.
69. Zhang, H., Vutskits, L., Pepper, M. S., and Kiss, J. Z. (2003). VEGF is a chemoattractant for FGF-2-stimulated neural progenitors. J. Cell Biol. 163, 1375-1384.